IBRX

ImmunityBio (IBRX)

About ImmunityBio (IBRX)

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Details

Daily high

$3.72

Daily low

$3.19

Price at open

$3.20

52 Week High

$10.53

52 Week Low

$1.25

Market cap

2.5B

Dividend yield

0.00%

Volume

3.1M

Avg. volume

2.5M

P/E ratio

-3.90

ImmunityBio News